What will happen, or is happening, with a clinical
Post# of 1460
But, if 80% of the people in the clinical trial DO have it, and maybe half of them respond, that would still be a 40% efficacy rate, which would be enough to get it approved.
All figures pulled out of thin air, of course.
We really need a blood test for Alzheimer's but I haven't heard about anyone getting to the point of actually filing for approval yet.